182 related articles for article (PubMed ID: 1909136)
1. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse.
Campbell IL; Oxbrow L; Harrison LC
J Autoimmun; 1991 Apr; 4(2):249-62. PubMed ID: 1909136
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
[TBL] [Abstract][Full Text] [Related]
3. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
Rabinovitch A
Diabetes Metab Rev; 1998 Jun; 14(2):129-51. PubMed ID: 9679667
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans.
Campbell IL; Iscaro A; Harrison LC
J Immunol; 1988 Oct; 141(7):2325-9. PubMed ID: 3139756
[TBL] [Abstract][Full Text] [Related]
6. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
[TBL] [Abstract][Full Text] [Related]
7. IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction.
Wachlin G; Augstein P; Schröder D; Kuttler B; Klöting I; Heinke P; Schmidt S
J Autoimmun; 2003 Jun; 20(4):303-12. PubMed ID: 12791316
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice.
Hill DJ; Petrik J; Arany E; McDonald TJ; Delovitch TL
J Endocrinol; 1999 Apr; 161(1):153-65. PubMed ID: 10194539
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse.
Campbell IL; Oxbrow L; Koulmanda M; Harrison LC
J Immunol; 1988 Feb; 140(4):1111-6. PubMed ID: 2963859
[TBL] [Abstract][Full Text] [Related]
10. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
[TBL] [Abstract][Full Text] [Related]
11. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
12. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma.
Debray-Sachs M; Carnaud C; Boitard C; Cohen H; Gresser I; Bedossa P; Bach JF
J Autoimmun; 1991 Apr; 4(2):237-48. PubMed ID: 1909135
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MHC protein expression in pancreatic beta-cells by interferon-gamma and tumor necrosis factor-alpha.
Campbell IL; Oxbrow L; West J; Harrison LC
Mol Endocrinol; 1988 Feb; 2(2):101-7. PubMed ID: 3135484
[TBL] [Abstract][Full Text] [Related]
14. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
15. Effects of prolonged exposure in vitro to interferon-gamma and tumour necrosis factor-alpha on nitric oxide and insulin production of rat pancreatic islets.
Sternesjö J; Bendtzen K; Sandler S
Autoimmunity; 1995; 20(3):185-90. PubMed ID: 7578879
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide.
Cetkovic-Cvrlje M; Eizirik DL
Cytokine; 1994 Jul; 6(4):399-406. PubMed ID: 7948748
[TBL] [Abstract][Full Text] [Related]
17. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
Pakala SV; Chivetta M; Kelly CB; Katz JD
J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
[TBL] [Abstract][Full Text] [Related]
18. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
19. Administration of interferon (IFN)-α exacerbates reovirus type-2-triggered autoimmune insulitis in DBA/1J mice.
Nakashima T; Hayashi T; Yamamoto Y; Mizuno T
Scand J Immunol; 2012 Oct; 76(4):378-86. PubMed ID: 22803632
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effect of IFN-gamma plus TNF-alpha on human islet cells.
Soldevila G; Buscema M; Doshi M; James RF; Bottazzo GF; Pujol-Borrell R
J Autoimmun; 1991 Apr; 4(2):291-306. PubMed ID: 1909137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]